Gong Cha

CHA Biotech Co., South Korea’s leading stem cell therapeutics developer, plans to resume an initial public offering of CHA Healthcare Co., a m...

South Korea's CHA Healthcare Co., CHA Biotech's overseas medical business affiliate incorporated Singapore's SMG as a subsidiary. CHA Healthcare an...

Global leading bubble tea franchise Gong Cha Global Ltd.’s South Korean affiliate, which owns the beverage chain’s Japanese and Taiwanes...

CHA Healthcare Co. operating nearly 90 hospitals and infertility treatment centers across the world, is set to pave the way for South Koreans' inves...

Cha Biotech, a South Korean biotechnology company, said on Thursday that it agreed to sell its technology for developing eye-cell therapies to Astel...

Cha Bio Group, consisting of Cha Biotech and Cha Vaccine Research Institute as its subsidiaries, has announced its expansion into the real estate in...

South Korea’s medical center operator CHA Healthcare Co. said on Monday it has acquired the management rights of Fertility Specialists of West...

CHA Biotech, South Korea’s stem cell therapeutics developer, is set to expand its biomaterials contract development and manufacturing organiza...

Cha Hoon, the former head of real estate investment at Korea Investment Corporation (KIC) is moving to Abu Dhabi’s state holding firm Abu Dhab...

The head of real estate investment at Korea Investment Corporation (KIC) has resigned from the South Korean sovereign wealth fund. Cha Hoon, appoint...

South Korea-based Unison Capital Inc. has signed a definitive agreement to sell milk tea brand Gong Cha to US private equity firm TA Associates for ar...

Unison Capital Inc. is in the final stages of negotiations to sell Taiwan-style milk tea brand Gong Cha to US private equity firm TA Associates for ar...

Private equity firm Unison Capital Inc. has put bubble tea franchise Gong Cha on the market, a deal estimated at up to $442 million, as the South Kore...